Clinical trial
OT-551 Antioxidant Eye Drops to Treat Geographic Atrophy in Age-Related Macular…
NCT00306488 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00306488 |
|---|---|
| Title | OT-551 Antioxidant Eye Drops to Treat Geographic Atrophy in Age-Related Macular Degeneration |
| Official title | A Phase II Study of OT-551 Antioxidant Eye Drop in Participants With Bilateral Geographic Atrophy Associated With Age-Related Macular Degeneration |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Collaborators | National Eye Institute (NEI) NIH Othera Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Geographic Atrophy, Age-Related Macular Degeneration, AMD |
| Intervention type | Drug |
| Interventions | OT-551 antioxidant eye drop |
| Enrollment | 11 |
| Start date | Mar 1, 2006 |
| Primary completion | Mar 1, 2010 |
| Completion | Mar 1, 2010 |
| First posted | Mar 23, 2006 |
| Last update posted | Jul 14, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: